The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 11, 2011, Pages 1817-1821

  Chen, Chiung Yu ^a   Tsai, Wei Lun ^b   Lin, Po Ju ^a   Shiesh, Shu Chu ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chronic liver disease; Ischemia modified albumin ratio; Liver cirrhosis

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; HUMAN ALBUMIN; ISCHEMIA MODIFIED ALBUMIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; ISCHEMIA SERUM ALBUMIN RATIO; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PARAMETERS OF MEASUREMENT AND ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UREMIA;

ADULT; AGED; BILIRUBIN; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; CREATININE; FEMALE; HEPATITIS; HUMANS; INDOCYANINE GREEN; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; TAIWAN; UREMIA;

EID: 80755171209     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.675     Document Type: Article

References (21)

1. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005;41:1211-9. (Pubitemid 40770271)
2. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett 2008; 582:1783-7.
3. Oettl K, Stadlbauer V, Petter F, Greilberger J, Putz-Bankuti C, Hallstrom S, et al. Oxidative damage of albumin in advanced liver disease. Biochim Biophys Acta 2008;1782:469-73.
4. Anraku M, Yamasaki K, Maruyama T, Kragh-Hansen U, Otagiri M. Effect of oxidative stress on the structure and function of human serum albumin. Pharm Res 2001;18:632-9. (Pubitemid 32595791)
5. Gaze DC. Ischemia-modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metab Pharmacokinet 2009;24:333-41.
6. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-5. (Pubitemid 36379523)
7. Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes - review and clinical implications. Clin Chem Lab Med 2011;49:177-84
8. Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007;23:216-20. (Pubitemid 46239165)
9. Lippi G, Montagnana M, Guldi GC. Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol 2006;108:410-1. (Pubitemid 43339816)
10. Refaai MA, Wright RW, Parvin CA, Gronowski AA, Scott MG, Eby CS. Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery. Clin Chim Acta 2006;366:264-8. (Pubitemid 43330993)
11. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, et al. Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study. Am J Emerg Med 2008;26:202-5. (Pubitemid 351215796)
12. Jalan R, Schnurr K, Mookerjee RP, Sen S, Cheshire L, Hodges S, et al. Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology 2009;50:555-64.
13. Shiesh SC, Chen CY, Lin XZ, Liu ZA, Tsao HC. Melatonin prevents pigment gallstone formation induced by bile duct ligation in guinea pigs. Hepatology 2000;32:455-60.
14. Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 2004;50:2190-3. (Pubitemid 39425871)
15. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, et al. Ischemia-modified albumin predicts mortality in ESRD. Am J Kidney Dis 2006;47:493-502. (Pubitemid 43255184)
16. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006; 92:113-4. (Pubitemid 43021873)
17. Okochi O, Kaneko T, Sugimoto H, Inoue S, Takeda S, Nakao A. ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res 2002;103:109-13. (Pubitemid 34953399)
18. Fazakas J, Mandli T, Ther G, Arkossy M, Pap S, Fule B, et al. Evaluation of liver function for hepatic resection. Transplant Proc 2006;38:798-800.
19. Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988;94:1493-502.
20. Sort P, Navasa M, Arroyo V, Planas R, Panes J, Viver J, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-9. (Pubitemid 29362513)
21. Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 2002;36:941-8.